EMEA-001398-PIP02-13
Key facts
Active substance |
|
Therapeutic area |
Diagnostic
|
Decision number |
P/0299/2013
|
PIP number |
EMEA-001398-PIP02-13
|
Pharmaceutical form(s) |
Powder and solvent for solution for injection
|
Condition(s) / indication(s) |
Diagnosis of beta-lactam allergy
|
Route(s) of administration |
|
Contact for public enquiries |
Diater Laboratorio de Diagnóstico y Aplicaciones Terapéuticas, S.A.
|
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
Compliance procedure number |
EMEA-C-001398-PIP02-13
|
Compliance opinion date |
12/09/2014
|
Compliance outcome |
positive
|